STRATA Skin Sciences Inc. (SSKN)
NASDAQ: SSKN
· Real-Time Price · USD
1.82
0.01 (0.55%)
At close: Aug 15, 2025, 2:15 PM
STRATA Skin Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -11.54M | -9.15M | -10.09M | -9.38M | -8.31M | -11.36M | -10.83M | -7.2M | -7.14M | -5.88M | -5.55M | -6.24M | -5.76M | -2.79M | -2.71M | -2.3M | -3.03M | -5.79M |
Depreciation & Amortization | 5.24M | 5.27M | 5.31M | 5.36M | 5.58M | 5.74M | 5.9M | 6M | 5.84M | 5.78M | 5.69M | 5.36M | 5.05M | 4.58M | 4.09M | 3.83M | 3.65M | 3.71M |
Stock-Based Compensation | 409K | 444K | 427K | 590K | 901K | 1.09M | 1.3M | 1.21M | 1.32M | 1.42M | 1.47M | 1.35M | 1.22M | 1.35M | 1.64M | 1.95M | 2.04M | 1.86M |
Other Working Capital | 264K | 1.84M | 1.7M | 1.99M | -844K | -455K | -799K | -585K | -131K | -467K | -223K | 98K | 635K | 331K | 801K | 973K | 1.35M | 111K |
Other Non-Cash Items | 3.9M | 3.77M | 3.85M | 2.67M | 1.69M | 1.74M | 1.42M | -882K | 240K | 237K | 358K | 1.87M | 1.79M | -226K | -347K | -1.96M | -2.01M | 58K |
Deferred Income Tax | n/a | n/a | n/a | -120K | -156K | 734K | 734K | 894K | 930K | 40K | 40K | -1.5M | -1.5M | -1.5M | -1.49M | 59K | 127K | 170K |
Change in Working Capital | -102K | 114K | 688K | 1.87M | -430K | 911K | -69K | -3.07M | -2.92M | -3.51M | -3.07M | -1.23M | -41K | -412K | 324K | -398K | 516K | 1.64M |
Operating Cash Flow | -2.09M | 442K | 188K | 991K | -727K | -1.14M | -1.54M | -3.05M | -1.73M | -1.96M | -1.11M | -434K | 712K | 1M | 1.51M | 1.19M | 1.28M | 1.65M |
Capital Expenditures | -704K | -1.11M | -1.64M | -2.98M | -3.75M | -4.34M | -5.02M | -4.68M | -4.38M | -4.28M | -3.55M | -3.17M | -3.7M | -3.59M | -3.65M | -3.23M | -2.9M | -2.3M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -631K | n/a | n/a | -631K | -3.47M | -7.58M | -7.58M | -6.95M | -3.47M | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 1.02M | 1.02M | 1.02M | 1.65M | n/a | n/a | -631K | 2.21M | -631K | -631K | -654K | -6.26M | -2.79M | -2.79M |
Investing Cash Flow | -704K | -1.11M | -1.64M | -2.98M | -2.73M | -3.31M | -4M | -3.66M | -4.38M | -4.28M | -4.18M | -3.8M | -7.8M | -7.7M | -7.13M | -6.71M | -2.9M | -2.3M |
Debt Repayment | n/a | n/a | n/a | n/a | -97K | -97K | -97K | -97K | n/a | n/a | n/a | n/a | 92K | 92K | 92K | 92K | n/a | 2.53M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -18K | -6.88M | -6.89M | 79K | 97K | 6.46M | 6.46M | -500K | -500K | -92K | -92K | -92K | -92K | 18K | 18K | 18K |
Financial Cash Flow | 1.94M | 1.94M | 1.93M | -4.94M | -6.98M | -18K | n/a | 6.36M | 6.46M | -500K | -500K | -92K | n/a | n/a | n/a | 110K | 18K | 2.55M |
Net Cash Flow | -851K | 1.27M | 477K | -69K | -3.58M | 2.38M | 1.32M | -350K | 359K | -6.74M | -5.79M | -4.23M | -7M | -6.6M | -5.53M | -5.41M | -1.59M | 1.89M |
Free Cash Flow | -2.79M | -668K | -1.45M | -1.99M | -3.46M | -4.46M | -5.54M | -6.71M | -6.11M | -6.24M | -4.66M | -3.6M | -2.98M | -2.59M | -2.15M | -2.05M | -1.61M | -652K |